BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

655 related articles for article (PubMed ID: 11911756)

  • 1. Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial.
    Cuffe MS; Califf RM; Adams KF; Benza R; Bourge R; Colucci WS; Massie BM; O'Connor CM; Pina I; Quigg R; Silver MA; Gheorghiade M;
    JAMA; 2002 Mar; 287(12):1541-7. PubMed ID: 11911756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heart failure etiology and response to milrinone in decompensated heart failure: results from the OPTIME-CHF study.
    Felker GM; Benza RL; Chandler AB; Leimberger JD; Cuffe MS; Califf RM; Gheorghiade M; O'Connor CM;
    J Am Coll Cardiol; 2003 Mar; 41(6):997-1003. PubMed ID: 12651048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rationale and design of the OPTIME CHF trial: outcomes of a prospective trial of intravenous milrinone for exacerbations of chronic heart failure.
    Cuffe MS; Califf RM; Adams KF; Bourge RC; Colucci W; Massie B; O'Connor CM; Pina I; Quigg R; Silver M; Robinson LA; Leimberger JD; Gheorghiade M
    Am Heart J; 2000 Jan; 139(1 Pt 1):15-22. PubMed ID: 10618557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group.
    Packer M; Carver JR; Rodeheffer RJ; Ivanhoe RJ; DiBianco R; Zeldis SM; Hendrix GH; Bommer WJ; Elkayam U; Kukin ML
    N Engl J Med; 1991 Nov; 325(21):1468-75. PubMed ID: 1944425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of intravenous milrinone followed by titration of high-dose oral vasodilator therapy on clinical outcome and rehospitalization rates in patients with severe heart failure.
    Cusick DA; Pfeifer PB; Quigg RJ
    Am J Cardiol; 1998 Nov; 82(9):1060-5. PubMed ID: 9817482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Racial differences in the characteristics of patients admitted for acute decompensated heart failure and their relation to outcomes: results from the OPTIME-CHF trial.
    Echols MR; Felker GM; Thomas KL; Pieper KS; Garg J; Cuffe MS; Gheorghiade M; Califf RM; O'Connor CM
    J Card Fail; 2006 Dec; 12(9):684-8. PubMed ID: 17174228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical trials update: OPTIME-CHF, PRAISE-2, ALL-HAT.
    Thackray S; Witte K; Clark AL; Cleland JG
    Eur J Heart Fail; 2000 Jun; 2(2):209-12. PubMed ID: 10856736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Symptomatic improvement in patients treated with intermittent infusion of inotropes: a double-blind placebo controled pilot study.
    López-Candales A; Vora T; Gibbons W; Carron C; Simmons P; Schwartz J
    J Med; 2002; 33(1-4):129-46. PubMed ID: 12939113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes associated with vasoactive therapy in patients with acute decompensated heart failure.
    Arnold LM; Crouch MA; Carroll NV; Oinonen MJ
    Pharmacotherapy; 2006 Aug; 26(8):1078-85. PubMed ID: 16863484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of dobutamine versus milrinone therapy in hospitalized patients awaiting cardiac transplantation: a prospective, randomized trial.
    Aranda JM; Schofield RS; Pauly DF; Cleeton TS; Walker TC; Monroe VS; Leach D; Lopez LM; Hill JA
    Am Heart J; 2003 Feb; 145(2):324-9. PubMed ID: 12595851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicenter, double-blind study of intravenous milrinone for patients with acute heart failure in Japan. Japan Intravenous Milrinone Investigators.
    Seino Y; Momomura S; Takano T; Hayakawa H; Katoh K
    Crit Care Med; 1996 Sep; 24(9):1490-7. PubMed ID: 8797620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Inpatient Dobutamine versus Milrinone on Out-of-Hospital Mortality in Patients with Acute Decompensated Heart Failure.
    King JB; Shah RU; Sainski-Nguyen A; Biskupiak J; Munger MA; Bress AP
    Pharmacotherapy; 2017 Jun; 37(6):662-672. PubMed ID: 28475215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Admission or changes in renal function during hospitalization for worsening heart failure predict postdischarge survival: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF).
    Klein L; Massie BM; Leimberger JD; O'Connor CM; Piña IL; Adams KF; Califf RM; Gheorghiade M;
    Circ Heart Fail; 2008 May; 1(1):25-33. PubMed ID: 19808267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term intravenous milrinone for severe congestive heart failure: the good, bad, and not so good.
    Varriale P; Ramaprasad S
    Pharmacotherapy; 1997; 17(2):371-4. PubMed ID: 9085331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of empiric nesiritide or milrinone infusion on early postoperative recovery after Fontan surgery: a randomized, double-blind, placebo-controlled trial.
    Costello JM; Dunbar-Masterson C; Allan CK; Gauvreau K; Newburger JW; McGowan FX; Wessel DL; Mayer JE; Salvin JW; Dionne RE; Laussen PC
    Circ Heart Fail; 2014 Jul; 7(4):596-604. PubMed ID: 24906491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intermittent milrinone effect on long-term hemodynamic profile in patients with severe congestive heart failure.
    Hatzizacharias A; Makris T; Krespi P; Triposkiadis F; Voyatzi P; Dalianis N; Kyriakidis M
    Am Heart J; 1999 Aug; 138(2 Pt 1):241-6. PubMed ID: 10426834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Response to milrinone treatment in patients with chronic congestive heart failure].
    Zeng H; Wen S; Huang D; Liu X; Fang Y
    Hua Xi Yi Ke Da Xue Xue Bao; 2000 Jun; 31(2):246-7, 259. PubMed ID: 12515150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outpatient parenteral inotropic therapy for advanced heart failure.
    Young JB; Moen EK
    J Heart Lung Transplant; 2000 Aug; 19(8 Suppl):S49-57. PubMed ID: 11016488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of oral milrinone, digoxin, and their combination in the treatment of patients with chronic heart failure.
    DiBianco R; Shabetai R; Kostuk W; Moran J; Schlant RC; Wright R
    N Engl J Med; 1989 Mar; 320(11):677-83. PubMed ID: 2646536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Canadian multicentre study of a 48 h infusion of milrinone in patients with severe heart failure.
    Pflugfelder PW; O'Neill BJ; Ogilvie RI; Beanlands DS; Tanser PH; Tihal H; Mizgala HF; Fitchett DH; Kostuk WJ
    Can J Cardiol; 1991; 7(1):5-10. PubMed ID: 2025794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.